Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy with oxaliplatin for peritoneal mesothelioma: Preliminary results and survival analysis
Surgical Oncology 2015 January 8 [Epub ahead of print] [Link] Hubert J, Thiboutot E, Dubé P, Cloutier AS, Drolet P, Sideris L. Abstract Background Peritoneal mesothelioma is a rare disease with poor prognosis. The present study reports single center experience with cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy with oxaliplatin (HIPEC-OX) over an eight-year period. […]